ANTENGENE

Summary

Antengene operates as a specialty pharmaceutical company. The Company produces innovative drugs, selinexor, eltanexor, verdinexor, and other products. Antengene provides its services throughout China.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 72 M

Avg. Deal Size£ 72 M

Market Context

Senior Management

Jay Mei
CEO

Sort

19 Jul 2020|China|Pharmaceuticals

Target: ANTENGENE

Bidder: BOYU CAPITAL

7 Service Providers

1 Target | 6 Bidder

18 Dealmakers

1 Target | 18 Bidder

£ 72 M

Value

Explore deals beyond your search with a free MergerLinks account.

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy